Rituximab: the Lupus Journey
Authors:
- 6 January 2015
- journal article
- research article
- Published by Springer Nature in Current Treatment Options in Rheumatology
- Vol. 1 (1) , 30-41
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus ErythematosusAutoimmune Diseases, 2014
- Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus – report of 17 cases and review of the literatureLupus, 2013
- Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritisLupus, 2013
- Long-term follow-up in lupus nephritis patients treated with rituximab--clinical and histopathological responseRheumatology, 2013
- Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB studyLupus, 2012
- Rituximab induces a rapid and sustained remission in Colombian patients with severe and refractory systemic lupus erythematosusLupus, 2011
- Current and novel therapeutics in the treatment of systemic lupus erythematosusJournal of Allergy and Clinical Immunology, 2011
- Rituximab Therapy in Lupus Nephritis: Current Clinical EvidenceClinical Reviews in Allergy & Immunology, 2010
- Systemic Lupus ErythematosusNew England Journal of Medicine, 2008
- An open study of B lymphocyte depletion in systemic lupus erythematosusArthritis & Rheumatism, 2002